Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based COO’ operating in the Medical space. If you think a COO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
David Deacon
Co Founder, COO of Ria Health
Follow David Deacon:
About Ria Health: Ria Health’s evidence-based telehealth alcohol treatment program helps people drink less and live better.
_______
Jennifer Jacobs
Co-Founder COO of PerceptiMed
Follow Jennifer Jacobs:
About PerceptiMed: PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.
Gene Castagnini
COO, CFO, CAO & Co-founder of Biocare Medical
Gene J. Castagnini, MS, MBA, co-founded Biocare Medical LLC in 1997 and serves as its Co-Owner and Chief Financial Officer. Gene Castagnini serves as the Chief Operating Officer and Executive Vice President of Biocare Medical, LLC Gene Castagnini served as the Chief Administrative Officer and Chief Financial Officer of BioGenex Laboratories. Inc., for 10 years. Gene Castagnini’s experience includes 15 years as a Director and Officer of Medi-Physics Inc., formerly a Hoffmann-La Roche Inc. subsidiary. Gene Castagnini has a BS in accounting and an MBA in Human Resource Management from the California State University school systems.
Follow Gene Castagnini:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Julie Skaff
Chief Operating Officer of Viz
Julie is Head of Operations at OODA Health.Prior to OODA she served as the Vice President of Implementation & Account Management at Grand Rounds, Inc. She managed the growth in their customer base to more than 80 direct customers. Prior to Grand Rounds, Julie was the Director of Implementation at Castlight Health, where she led the strategic implementation group. Julie has also worked in Booz & Company’s Global Health Practice and served Senator Dianne Feinstein as an aide for taxes, budget, and commerce. Julie has an MBA from the Tuck School of Business at Dartmouth and a BA from Northwestern University.
Follow Julie Skaff:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Vivien Chan
COO of Eureka Therapeutics
Vivien Chan serves as the Chief Operating Officer at Eureka Therapeutics.
Follow Vivien Chan:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Jacqualyn Fouse
President and Chief Operating Officer of Celgene
Dr. Fouse serves as President and Chief Operating Officer. She assumed that role on March 1, 2016. In February 2016, Dr. Fouse was elected to the Board of Directors. Previously she was President, Global Hematology and Oncology since July 2014. Dr. Fouse joined the Company in September 2010 as Senior Vice President and Chief Financial Officer and became Executive Vice President and Chief Financial Officer in February 2012. Before Celgene, Dr. Fouse served as Chief Financial Officer of Bunge Limited, a leading global agribusiness and food company (Bunge), starting in July 2007. Before Bunge, Dr. Fouse was at Alcon Laboratories serving as Senior Vice President, Chief Financial Officer, and Head of Corporate Strategy at Alcon Laboratories between 2002 and 2007. Dr. Fouse was the Chief Financial Officer at Swissair Group from 2001 to 2002. Dr. Fouse held a variety of senior finance positions at Nestlé S.A. from 1993 to 2001, including serving as Group Treasurer of Nestlé from 1999 to 2001. Dr. Fouse also worked in finance at Alcon from 1986 to 1993 and held several positions, including Manager Corporate Investments and Domestic Finance. Earlier in her career, she worked at Celanese Chemical and LTV Aerospace and Defense. Dr. Fouse earned a B.A. and an M.A. in Economics and a Ph.D. in Finance from the University of Texas at Arlington. Dr. Fouse also serves as a member of the Board of Directors of Dick’s Sporting Goods (chairperson of the audit committee) and Perrigo Company (member of the audit committee), both NYSE-listed companies.
Follow Jacqualyn Fouse:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Steven Ertel
Chief Operating Officer of Acceleron Pharma
Mr. Ertel joined Acceleron in January 2006 as a Chief Operating Officer. Mr. Ertel established Acceleron’s business development function and currently leads business development, commercial strategy and program management functions. Mr. Ertel has over 20 years of experience in the biotechnology industry at Vivus, Inc., Genentech, Inc., Biogen Idec, Inc., and Synta. His responsibilities at these companies included program management for preclinical and clinical stage programs, commercial strategy for clinical stage programs, market launch of a novel biologic agent, and business development. Mr. Ertel began his career in the venture capital industry at Oxford Bioscience Partners. Mr. Ertel received a BSE in biomedical engineering from Duke University and an MBA from the Wharton School at the University of Pennsylvania.
Follow Steven Ertel:
About Acceleron Pharma: Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Evan Roberts
Founder & COO of Phreesia
As VP of Customer Solutions and co-founder of Phreesia, Inc., Evan is the technical visionary responsible for driving Phreesia’s initiative to pioneer patient self-service registration and educational solutions, at a low cost to clinicians in their medical practices. Prior to founding Phreesia, Evan was a Senior Sales Engineer at Spotfire, a leading provider of interactive analytics software, where he helped to penetrate new markets including pharmaceutical sales and marketing, resulting in significant net new revenue. In that capacity he developed innovative applications, and trained and managed his team to support and nurture these new markets. He began his career at Spotfire as a member of the Professional Services team. Evan holds a degree in Computer Engineering from Tufts University.
Follow Evan Roberts:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Nandini Ramani
Chief Operating Officer of Outcome Health
Nandini Ramani is the COO of Outcome Health.
Follow Nandini Ramani:
About Makers, Outcome Health: Outcome Health delivers better health outcomes and impacts the human condition positively through technology.
Matthew Chaiken
Co-founder & COO of Blink Health
Matthew is the co-founder and COO of Blink Health. He has been responsible for overseeing the creation of the first e-commerce experience in pharmacy and currently oversees product, engineering, marketing, customer experience and analytics across the company. Prior to co-founding Blink, Matthew served as an investment professional at Marble Arch Investments – a New York-based investment firm – where he was responsible for many of the firm’s technology and consumer product investments. Prior to his time at Marble Arch, Matthew was an investment professional at Merchants’ Gate Capital, specializing in the retail, industrials and business services industries. Before joining Merchants’ Gate, Matthew served as an investment banker for Citigroup after graduating from Yale with a BA in Biology.
Follow Matthew Chaiken:
About Blink Health: Blink Health is a web-based application that enables users to search for medical prescriptions online and pick them up from any pharmacy.
Matthew Chance
President & Chief Operating Officer of myNEXUS
As Chief Operating Officer Matt is responsible for providing strategic direction, product innovation, and valuebased network models within the delivery system. Prior to joining myNEXUS Matt provided strategic and operational oversight for all Health Engagement Initiatives for Cigna-Healthspring. These areas include Stars, Risk Adjustment, Utilization Management, Clinical Programs and Customer retention. These activities drove revenue and quality optimization related to all Medicare Advantage customers based on their unique needs. Matt worked with HealthSpring for 9 years, and was the COO of Healthspring of Alabama before moving to Cigna-HealthSpring enterprise operations. While in Alabama he helped develop various aligned incentive models to better connect the Healthplan and Provider community. Matt began his career in healthcare working with Hospitals and Insurers at AIM Healthcare Services. He lead operations for the Southeast region and was with AIM for 5 years.
Follow Matthew Chance:
About myNEXUS, myNEXUS: myNEXUS is a healthcare management system that enables doctors to remotely monitor their patients’ health.
Clarissa Shen
COO of Q Bio
Clarissa Shen is Chief Operating Officer and Board Member at Q. She is an international executive and entrepreneur who enjoys scaling high-growth teams who are on a mission to change the world for good. Most recently, she was COO at Udacity, where she joined as the first business hire and helped grow the company from $0 to $100MM revenue run rate. She started her career in management strategy consulting at Monitor Group (now Deloitte Monitor) advising Fortune 500 executives and companies in Greater China, Southeast Asia, and Europe. In her past life, she has led a top 10 Google digital marketing team, managed an internationally-touring contemporary dance company, and co-founded a pioneering K-12 foreign language education start-up. Clarissa graduated magna cum laude from Williams College and has an MBA from Harvard Business School.
Follow Clarissa Shen:
About Q Bio: On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Matt Kennedy
Co-Founder, COO of Mantra Health
Follow Matt Kennedy:
About Mantra Health: Mantra Health is a digital mental healthcare company designed for all university students.
Matthew Ko
Co-founder and COO of DeepScribe
Follow Matthew Ko:
About DeepScribe: DeepScribe is an AI-driven platform for medical record-taking.
Sean Jeffries
Chief Operating Officer of Design Therapeutics
Sean Jeffries is the Chief Operating Officer at Design Therapeutics.
Follow Sean Jeffries:
About Design Therapeutics: Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Michael Staffieri
Chief Operating Officer, Kidney Care of DaVita Healthcare Partners
Michael Staffieri became our chief operating officer, Kidney Care, in March 2014. From July 2011 to February 2014, he served as a senior vice president, Kidney Care. From March 2008 to July 2011, he served as our vice president of operations and new center development. Mr. Staffieri joined the Company in July 2000 and has served in several different roles. Prior to joining us, Mr. Staffieri worked for Arthur Andersen LLP in Finance from 1999 to 2000.
Follow Michael Staffieri:
About DaVita Healthcare Partners: DaVita® and HealthCare Partners® have joined forces to become one of the nation’s largest and most innovative healthcare communities.
Jeff Brizzolara
Chief Operating Officer of Wellthy
Jeff Brizzolara is the chief operating officer of Wellthy.
Follow Jeff Brizzolara:
About HERO Health, Wellthy: Wellthy is a family care concierge service that brings relief to families managing complex or ongoing care situations.
Paul LaViolette
Managing Partner, Chief Operating Officer of SV Health Investors
Paul brings over 33 years of global medical technology management experience. Paul was most recently Chief Operating Officer at Boston Scientific Corporation (BSC), an $8 billion medical device leader. During his 15 years at BSC, he served as COO, Group President, President-Cardiology and President-International as the company grew revenues over 20 times. Paul integrated two dozen acquisitions and led extensive product development, operations and worldwide commercial organizations. Paul previously held marketing and general management positions at CR Bard, and various marketing roles at Kendall (Covidien). He served on the boards of Urologix, Percutaneous Valve Technologies and Advamed and currently serves on the boards of *Baxano Surgical, *Cardiofocus, CardioKinetix, Coridea NC2, CSA Medical, *DC Devices, *Direct Flow Medical, Thoratec, *TransEnterix, ValenTx and the Medical Device Manufacturers Association (MDMA). Paul received his BA in Psychology from Fairfield University and his MBA from Boston College.
Follow Paul LaViolette:
About CardioFocus, Medtech Convergence Fund, SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Mike Nill
Chief Operating Officer of Cerner
As executive vice president and chief operating officer, Mike Nill is responsible for Cerner’s core worldwide business operations including intellectual property, consulting, information technology (IT) transformation, infrastructure, managed services and client support. He improves the quality and effectiveness of Cerner’s delivery organizations by aligning all aspects of the development process, from implementation through management and support. A software engineer by background, Mike began his Cerner career in 1996, rolling out Cerner Millennium® solutions. During this time he built capabilities to help clients effectively implement and manage their technology infrastructure. During his time at Cerner, Mike has led the development of several new offerings, including Cerner ITWorksSM, a world-class remote hosting offering. He also spearheaded the Cerner ITWorksSM offering, which further aligns the company with clients to improve quality and lower costs. Under his leadership, Cerner’s $4.9 billion cumulative research and development investment has resulted in Cerner solutions having the highest code quality in company history, resulting in the most complete set of integrated capabilities in the health care industry. Mike is a graduate of Rockhurst University and has a bachelor’s degree in computer information systems.
Follow Mike Nill:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Jeff Yordon
President & COO of Athenex
Jeffrey Yordon has held multiple senior management positions in the pharmaceutical industry over the last 46 years. Mr. Yordon was the Founder, Chairman and CEO of Sagent Pharmaceuticals which had a market cap of $1.6 billion when he left the company in 2015. Previous to that, Mr. Yordon was the COO of American Pharmaceutical Partners where he was a founder and the company was eventually sold to Fresenius for $5.5 billion. Mr. Yordon was the CEO of Faulding Pharmaceuticals, CEO and Founder of YorPharm, COO of Gensia Pharmaceuticals and he was instrumental in the sale of all of these companies to Apotex, Teva and Hospira for prices upwards of $3.5 billion. Mr. Yordon has successfully taken four companies public and all of the companies sold for significant returns for his shareholders. Mr. Yordon was an Ernst & Young Entrepreneur of the Year in 2011, was inducted into the Chicago Entrepreneur Hall of Fame in 2014, won a prestigious Innovation Award from the City of Chicago, was appointed to the Chicago Innovation Council in 2014, was appointed by Governor Rauner to the Illinois Sports Facilities Authority in 2015, has been appointed to be the Chairman of the Board of the Northern Illinois University Foundation, is the Chair of the NIU Political Science Advisory Panel and is actively involved in the NIU Athletic program. Mr. Yordon has three children and presides in the Chicago area.
Follow Jeff Yordon:
About Athenex, Sagent Pharmaceuticals: Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases.
Scott Brame
President and Chief Operating Officer of Radialogica
Scott is a co-founder of Radialogica and serves as President and Chief Operating Officer. He was formerly an Assistant Professor of Radiation Oncology at Washington University in St. Louis and Chief of Clinical Development. He previously served as Senior Vice President of Clinical Design and Research at CMS, Inc. with global responsibility for product management and roadmap planning, and was a Research Fellow at Memorial Sloan-Kettering Cancer Center. Scott received his Ph.D. from the University of Tennessee and his MBA from the Olin School of Business at Washington University in St. Louis.
Follow Scott Brame:
About Radialogica: Radialogica is a bioinformatics company providing software solutions for radiation oncology and the healthcare market.
David Dill
President & COO of LifePoint Health
David Dill serves as the Company’s President and Chief Operating Officer. Prior to assuming his current position in April 2009, Mr. Dill served as the Company’s Executive Vice President and Chief Financial Officer since joining the Company in July 2007. Previously, Mr. Dill served as Executive Vice President of Fresenius Medical Care North America and as Chief Executive Officer in the East Division of Fresenius Medical Care Services, a wholly owned subsidiary of Fresenius Medical Care AG & Co. KGaA. Dill previously served as Executive Vice President, Chief Financial Officer and Treasurer of Renal Care Group, Inc., a publicly traded dialysis services company, from November 2003 until Renal Care Group was acquired by Fresenius Medical Care in March 2006. Mr. Dill is a former director of Psychiatric Solutions, Inc., a behavioral health services company.
Follow David Dill:
About LifePoint Health: LifePoint Health is a leading healthcare company dedicated to Making Communities Healthier.
Chris M. Calcaterra
Chief Operating Officer of Glaukos
Chris M. Calcaterra has served as our chief commercial officer since April 2008 and has more than 25 years of experience in the ophthalmic medical technology industry. Prior to joining our company, Mr. Calcaterra was senior vice president at Advanced Medical Optics, Inc. (acquired by Abbott Laboratories), and was responsible for its cataract refractive business. Prior to that position, Mr. Calcaterra held increasingly responsible vice president positions in a variety of sales and marketing roles at Advanced Medical Optics, Inc., as well as its predecessor surgical division business at Allergan, Inc. Mr. Calcaterra has a B.S. from Miami University and an M.B.A. from Xavier University, and he was previously a board member of WaveTec Vision Systems, Inc., (acquired by Novartis).
Follow Chris M. Calcaterra:
About Glaukos: Glaukos is a glaucoma treatment company developing micro-bypass therapies to moderate the intraocular pressures that help preserve vision.
Geoff Price
Chief Operating Officer and Co-Founder of Oak Street Health
Geoff Price is the Chief Operating Officer at Oak Street Health.
Follow Geoff Price:
About Oak Street Health: Oak Street Health is a network of primary care centers for adults on Medicare.
Pamela Hudson
Chief Operating Officer & Center for Digital Health Innovation of University of California, San Francisco
Pamela Hudson is the Chief Operating Officer & Center for Digital Health Innovation at UCSF.
Follow Pamela Hudson:
About BayHealth Development, Gordon and Betty Moore Foundation, UCSF health, University of California, San Francisco, University of California, San Francisco: Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Ryan Fukushima
Chief Operating Officer of Tempus
Ryan Fukushima serves as Chief Operating Officer at Tempus. Prior to Tempus, Fukushima was an Entrepreneur-in-Residence and Vice President at Lightbank, focusing investments on enterprise software and launching businesses. Earlier he was at Hyde Park Venture Partners, where he concentrated on enterprise investments in the Midwest. Before landing in Chicago, Fukushima worked predominantly as an engineer, designing and implementing backend systems for Cisco and VMware. Fukushima has received a bachelor’s degree in Engineering from California Polytechnic University and holds an MBA from the Ross School of Business at University of Michigan, where he was a Zell Scholar.
Follow Ryan Fukushima:
About Tempus: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
Anish Bhatnagar
Chief Executive Officer, President & Chief Operating Officer of Soleno Therapeutics
Dr. Bhatnagar was appointed as our Chief Executive Officer in February 2014. Prior to that, he served as our President and Chief Operating Officer. Dr. Bhatnagar joined us in 2006, and has held positions of increasing responsibility since then. Dr. Bhatnagar is a physician with over 15 years of experience in the medical device and biopharmaceutical industries. His experience spans development of biologics, drugs, drug-device combinations and diagnostic as well as therapeutic medical devices. His prior experience includes working at Coulter Pharmaceuticals, Inc. from 1998 to 2000 and Titan Pharmaceuticals, Inc. from 2000 to 2006. He is the author of several peer-reviewed publications, abstracts and book chapters. He obtained his medical degree at SMS Medical College in Jaipur, India and completed his Residency and Fellowship training in the U.S. at various institutions, including Georgetown University Hospital and the University of Pennsylvania.
Follow Anish Bhatnagar:
About Soleno Therapeutics: Soleno Therapeutics is a clinical-stage biopharmaceutical company
George Hillman
COO, VP & Co-Founder of Viracta Therapeutics
George Hillman is the Co-Founder, Chief Operating Officer, and Vice President of Viracta Therapeutics.
Follow George Hillman:
About Viracta Therapeutics: Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Jim Abrams
Chief Operating Officer of Medline Industries
Jim joined Medline in 1992 where he started as a sales representative. Since then he has held various management positions within the company until being named COO in 1997. He graduated from the University of Michigan with a Bachelor of Arts degree and earned his law degree from the University of Chicago. Upon graduation from U of C, he worked for the law firm Kirkland and Ellis.
Follow Jim Abrams:
About Medline Industries: Medline Industries, Inc., based in Mundelein, Illinois,
Mukul Jain
Chief Operating Officer of Senseonics
Mukul Jain is the Chief Operating Officer at Senseonics, Inc. Mukul is responsible for overseeing Quality, Regulatory, Product Development and Global Operations – including manufacturing and supply chain. Prior to joining Senseonics, Mukul spent 13 years at Medtronic working on active implantable devices in CRDM and Neuromodulation space. He was responsible for managing the development of Neurostimulator systems in spinal cord stimulation and sacral nerve stimulation. Prior to that, he worked at Medtronic Energy and Components Center developing various critical components used across Medtronic’s implantable devices. Mukul earned his MBA from Carlson School of Management at the University of Minnesota, a PhD in chemical engineering from the University of South Carolina and a B.Tech. from Indian Institute of Technology, Kanpur.
Follow Mukul Jain:
About Senseonics: Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Darren Sherman
President, Chief Operating Officer, Director and Founder of Orchestra BioMed
Darren Sherman is a Managing Partner of Orchestra. He is also Chief Technical Officer of Accelerated Technologies, Inc. (ATI) as well as Chief Executive Officer of Caliber Therapeutics, Inc., an OMV II Fund Portfolio Company. He has over 17 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, and neurovascular therapies. He currently serves as a director of Caliber Therapeutics and Vivasure Medical. Prior to joining Orchestra, Mr. Sherman held various positions in executive management for Cordis Neurovascular (CNV), a Johnson & Johnson company, including Executive Director R&D and Director of Strategic Marketing for stroke products. He had worldwide responsibility for all neurovascular R&D and global strategic marketing responsibilities for the Stroke franchise, including budgets, portfolio of products and strategic planning. Mr. Sherman made significant contributions to the design and commercialization of a series of key products including the Enterprise Vascular Reconstruction Device and the Orbit Embolic Coil as well as directed the filing of over 100 patents. Prior to joining CNV, Mr. Sherman played an integral role in the formation and development of Revivant Corp (acquired by Zoll) while working with Thomas J. Fogarty, MD at Fogarty Engineering. He was Revivant’s first employee and managed the design, development, and testing of the AutoPulse device from concept through market introduction. In addition to the R&D related activities, Mr. Sherman supported the clinical research, marketing, and intellectual property efforts. The AutoPulse is a lightweight, portable tool replacing the need for manual chest compressions during cardio-pulmonary resuscitation (CPR) for patients suffering from sudden cardiac arrest. Prior to Revivant, Mr. Sherman held positions in research and development for Cardiac Pathways Corp., prior to its acquisition by Boston Scientific, and Baxter Healthcare. In each of these companies, he participated in the creation, development and launch of products. Mr. Sherman has authored 45 U.S. patents with an additional 58 published applications. He earned a BS degree in Bioengineering from the University of California, San Diego.
Follow Darren Sherman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Narendra Lalwani
Executive Vice President of R & D and Chief Operating Officer of Esperion
Narendra Lalwani is Executive Vice President, R & D, and Chief Operating Officer. Prior to joining Esperion, Narendra was Chief Scientific Officer at Cerenis Therapeutics from 2007 to 2014 where he led R&D activities for the company. Previously, Narendra was Vice President of Drug Safety at the original Esperion until its acquisition by Pfizer. Prior to Esperion, Narendra held various positions of increasing responsibility in the Department of Pathology and Experimental Toxicology at Warner-Lambert/Parke-Davis. Narendra is a Fellow of American Heart Association (FAHA) and a diplomate of the American board of Toxicology (DABT).Narendra earned a Ph.D. in Biophysics from the University of Bombay (India) and an MBA from the University of Michigan, Ross School of Business.
Follow Narendra Lalwani:
About Esperion: Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Jon Adkins
COO and Co-founder of XenoTherapeutics
Jon Adkins, M.B.A., is COO and Co-founder of XenoTherapeutics Corporation.3 Jon graduated from the University of Florida and completed his Master of Business Administration with an emphasis in Healthcare Management from Southern New Hampshire University. Jon has spent more than 15 years in medical device sales, management, marketing, and consulting. He’s worked with top corporations, including Zimmer Biomet, DePuy Synthes, and Smith & Nephew. In these roles, he supervised simultaneous lines of business involving implantable medical devices and biologics, including those used in orthopedic joint reconstruction and spine and trauma surgeries. Jon combines his expertise in business development with industry experience to focus on implementing the strategic and operational directives of XenoTherapeutics.
Follow Jon Adkins:
About XenoTherapeutics: XenoTherapeutics is a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs.
Soren Therkelsen
Co-Founder and COO of Qvin
Soren Therkelsen is the Co-founder and COO at Qvin.
Follow Soren Therkelsen:
About Qvin, Sandbox, SCALEit: Qvin is a developer of a smart sanitary pad for women to proactively track their health.
Maria Opdycke
COO of First Stop Health
Follow Maria Opdycke:
About First Stop Health: We provide care that people love with 24/7 access to licensed doctors via app, web or phone.
R.J. Demman
COO of Vivera Pharamceuticals
R.J. Demman is the Chief Operations Officer of Vivera Pharmaceuticals. With over 20 years of comprehensive operations, relationship, and business development experience, Mr. Demman is well versed in the needs of high volume Companies. As Vice President of Relationship Marketing with several of the largest gaming institutions, Mr. Demman has crafted a number of high-level programs to increase revenue and growth while maintaining strong bonds with Tribal Councils, government regulators, and team members. Mr. Demman will use his extensive leadership and people skills to oversee the day-to-day operations and implement policies and procedures to promote Vivera’s continued growth.
Follow R.J. Demman:
About Vivera Pharamceuticals: Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California.
Elizabeth Reifsnyder
COO of Ritual
Elizabeth Reifsnyder is the COO of Ritual.
Follow Elizabeth Reifsnyder:
About Ritual: Ritual is a health technology company that is re-inventing consumer products.
Jonathan Lanfear
Chief Operating Officer of HiberCell
Follow Jonathan Lanfear:
About HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Pad (Padmanabh) Chivukula
Founder, CSO & COO of Arcturus Therapeutics
Padmanabh (Pad) Chivukula Ph.D., is Founder, Chief Scientific Officer, Chief Operating Officer and Director of Arcturus Therapeutics. He is responsible for Arcturus’ research and development activities, including clinical and non-clinical development and regulatory affairs for all of Arcturus drug products. Dr. Chivukula has an exceptional and technically solid foundation in nanoparticle technology. Prior to Arcturus, from 2008 until February 2013, Dr. Chivukula was employed by Nitto Denko Technical Corporation, a pharmaceutical company, where his titles included Group Leader and Chief Scientist. Dr. Chivukula brings over 15 years of experience in drug delivery and therapeutic drug development, including leading the polymeric RNAi research department at Nitto Denko.
Follow Pad (Padmanabh) Chivukula:
About Arcturus Therapeutics: Arcturus Therapeutics focuses on developing novel RNA therapeutics for the treatment of various diseases aiming at Rare Diseases.
Doug Teany
Chief Operating Officer of Corindus
Doug is a forward-thinking medical device executive with a 20+-year track record of driving operational excellence for research and product development organizations. He has contributed millions to top- and bottom-line growth of companies through operational improvement and implementation of emerging and disruptive technologies. Since joining Corindus in 2016, Doug has transformed the organization into a fast-growing, healthcare robotics company aimed at disrupting the current care model for stroke and heart attack. He has positioned Corindus as the global leader in vascular robotics through development of a second-generation robotic system and advanced capabilities in procedural automation and telerobotics. Under Doug’s leadership in 2018, Corindus completed the world’s first-in-human remote robotic interventional heart procedure. That was followed by the first in-human robotic neurovascular intervention in 2019. Prior to joining Corindus, Doug served as Vice President in Boston Scientific’s development organization, responsible for strategy and operations of its global clinical and preclinical research functions. He played a key role in returning BSC to profitability and growth by accelerating pivotal cardiovascular development programs and improving multiple large-scale laboratory and research facilities. Doug holds a Master of Science and Bachelor’s degree from Purdue University and served as an Engineer in the United States Army Reserves.
Follow Doug Teany:
About Corindus, Method AI: Corindus develops and commercializes remote robotic systems for interventional procedures.
Glenn Robertelli
Co-Founder & Chief Operating Officer of Admetsys
Follow Glenn Robertelli:
About Admetsys: For people at diabetic risk, glucose control is at its most crucial while in hospital or surgery.
Dave Anderson
Senior VP of Engineering & Chief Operating Officer of Atonarp
Follow Dave Anderson:
About Atonarp: Atonarp combines electronics and data processing algorithms for chemical composition analysis.
Jihye Shin
Co-founder & COO of GIBLIB
Follow Jihye Shin:
About GIBLIB: GIBLIB is a California-based company and is the “Netflix” of Medical Education.
Kate Blanchard
Chief Operating Officer / Founder of ORIG3N
Follow Kate Blanchard:
About ORIG3N: ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Tayson Siegel
Chief Operating Officer of Xip
Follow Tayson Siegel:
About Xip: Xip produces disposable blood analyzers that wirelessly upload lab-quality clinical measurements in minutes.
Jay Scherer
Chief Operating Officer of Conversant Bio
Jay has 17 years of software development and management experience in the defense, telecommunications, and biotechnology industries. From 2000 through 2009, he worked at ADTRAN where he most recently served as Engineering Manager in support of network management solutions for the SMB market. Prior to joining ADTRAN Jay worked for Davidson Enterprises, Nichols Research, and ADDI supporting defense, healthcare and corporate software development efforts. Jay holds a B.S. in Information Systems from Northwestern State and an MBA from Florida Tech.
Follow Jay Scherer:
About Conversant Bio, Discovery Life Sciences, Discovery Life Sciences: Conversant Bio serves as a trusted partner to many of the top biotech and pharma groups.
Jeffrey Nardoci
Chief Operating Officer of HydraFacial
Jeffrey Nardoci joined HydraFacial as the chief operating officer in April 2017. Prior to joining HydraFacial, Jeff served as Chief Commercial Officer for Syneron-Candela. Jeff brings more than 25 years of experience in leadership roles in healthcare, medical device and FMG with multinational corporations and industry leaders including Banner Health, Solta Medical, Bausch & Lomb, and Nabisco Brands.
Follow Jeffrey Nardoci:
About HydraFacial, INBRACE: HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.
Mary Z. Luo
COO, Chief Scientist of Amphastar Pharmaceuticals
Mary Z. Luo, Ph.D. has served as Chief Operating Officer for Amphastar Pharmaceuticals, Inc. and Chairman of the Board of Directors since its inception in 1996. She has also served as a Chief Scientist since 2005 and Corporate Secretary from 1996 through April 2004. As co-founder of both Amphastar Pharmaceuticals, Inc. and APCL, Dr. Luo has over 30 years of academic and practical experience in the field of chemistry. She provides scientific leadership through her research and activities in technology transfer, regulatory submission, intellectual property, clinical research, recruitment, and training. Dr. Luo is a professor emeritus of chemistry at California State Polytechnic University, Pomona and is named as the inventor on several U.S. and foreign patents. She received a Ph.D. in Chemistry from Princeton University and was a Post Doctoral Research Associate at the California Institute of Technology.
Follow Mary Z. Luo:
About Amphastar Pharmaceuticals: Amphastar Pharmaceuticals specialty pharmaceutical company that is engaged in the development, manufacture and marketing of generic.
Fred Daugherty
Chief Operating Officer of CSI Laboratories
Fred Daugherty is Chief Operating Officer at CSI Laboratories.
Follow Fred Daugherty:
About CSI Laboratories: CSI Laboratories has provided pathologists and clinicians with the diagnostic expertise.
Jun Yoon
Chief Operating Officer of ShouTi
Jun Yoon is the Chief Operating Officer at ShouTi.
Follow Jun Yoon:
About ShouTi: ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.
Stewart Roberts
Co-founder, President & COO of Biolinq
Stewart Roberts is the Co-founder, President, and COO of Biolinq.
Follow Stewart Roberts:
About Biolinq: Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.
Jared Tangney
Co-founder, President & COO of Biolinq
Jared Tangney joined Biolinq as Co-founder, President, and COO in November 2020. He earned a Doctor of Philosophy (Ph.D.) degree in Bioengineering and Biomedical Engineering at UC San Diego.
Follow Jared Tangney:
About Biolinq: Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.
Vikram Bakhru
Chief Operating Officer & Chief Financial Officer of ConsejoSano
Dr. Vik Bakhru is a physician, senior healthcare executive and entrepreneur who has served in numerous executive roles in healthcare and business. He is currently the Chief Operating Officer at ConsejoSano, a leading venture-backed health technology platform that enables payers and providers to simplify care, increase engagement and lower costs. Previously, Dr. Bakhru was Chief Operating Officer of First Opinion, Inc. Before First Opinion, Inc., Dr. Bakhru served as Chief Medical Officer for Abercrombie & Kent Global Health, a Fortress Investment Group portfolio company that facilitates high quality, affordable medical travel. In addition, Dr. Bakhru worked as a Director at New York Presbyterian Hospital/The University Hospital of Columbia and Cornell in New York City where he managed an annual spend base of approximately $600 million for the purchase of all clinical goods and services. Prior to his role at NYP, Dr. Bakhru worked with the Foundation for International Medical Relief of Children (FIMRC), a non-profit he founded while completing his medical degree at The George Washington University School of Medicine & Health Sciences in Washington, DC. FIMRC (www.fimrc.org) is a 501(c)3 non-profit organization dedicated to providing health care access in underserved areas of the developing world through a network of health centers in nine countries across 12 project sites. FIMRC now boasts a team of over 3,000 full-time staff and volunteers. Dr. Bakhru serves on the Board of Directors for several organizations including the Nanubhai Education Foundation, Aspire Global Health and FIMRC. Dr. Bakhru’s professional affiliations include membership in the American College of Surgeons, the American Medical Association and the American Telemedicine Association. He has been practicing medicine since 2007 and is currently a licensed physician in 17 states (AZ, CA, DC, FL, GA, IL, MA, MD, MI, NC, NY, OH, PA, UT, VA, WA, WI). He is clinically active as a private practitioner and as an on-call physician at UCSF Medical Center and Main Line Health. Dr. Bakhru earned a Bachelor of Arts in Economics and a Bachelor of Science in Biology from The George Washington University as part of the Seven-Year Integrated Medical Program. After his undergraduate and medical education in Washington, DC, Dr. Bakhru did residency training in general surgery in Philadelphia and subsequently earned a Master of Business Administration degree in Health Care Management from The Wharton School of the University of Pennsylvania. Recognitions include the American Medical Association Foundation Excellence in Leadership Award, The George Washington University Award, the Kaiser Family Foundation Grant, the Becker’s Hospital Review: Rising Stars in Healthcare Award, and most recently was named to the Wharton Forty Under Forty for 2017. Dr. Bakhru gives over a dozen keynote speeches and participates in numerous panel discussions per year. His topics include clinical medicine, digital health, entrepreneurship, global health, innovation, leadership, Medicaid/Medicare, patient engagement, product development & technology, social determinants of health, robotics, and user experience. He has presented at the Indian Institute of Management, HIMSS Precision Medicine Summit, Stanford Medicine X, HIMSS Pop Health Forum, 7th Digital Health London, HIMSS Digital & Personal Health Forum, UCLA Anderson Healthcare Conference, Entrepreneur’s Summit, MIT Sloan Healthcare & Bioinnovation Conference, Ayusmat Healthcare Leadership Summit and The Wharton School, University of Pennsylvania (Philadelphia, Pennsylvania).
Follow Vikram Bakhru:
About ConsejoSano, First Opinion Medical Services, Mir Ventures: Multicultural engagement and navigation solutions
Kip Young
President & COO of DoctorLogic
Follow Kip Young:
About DoctorLogic: DoctorLogic offers an EHR-integrated marketing service that helps doctors grow their practice.
Kamran Tavangar
Chief Operating Officer of Affinivax
Kamran Tavangar has over 20 years of experience in pharmaceuticals and vaccines. Prior to joining Affinivax, Dr. Tavangar was Vice President of Strategic Product Development at Visterra. Dr. Tavangar previously served in various operational and strategic positions with Novartis for 19 years. Most recently he was the Global Head of Strategic Planning at Novartis Vaccines and Diagnostics, subsequent to being Head of Strategic Global Marketing at Novartis Vaccines. Previously, Dr. Tavangar was the Business Unit Head for Novartis Oncology in Australia. He also served as VP Finance for Novartis Pharmaceuticals USA, as well as Head of Investor Relations for Novartis Corporation USA. Dr. Tavangar received his AB in Molecular Biology from UC Berkeley, PhD in Physiology from Stanford University, and MBA from MIT’s Sloan School of Management.
Follow Kamran Tavangar:
About Affinivax, Visterra: Affinivax is a biopharmaceutical company developing vaccines used to enhance the depth of protection against infectious diseases.
Jordan Curnes
Co-founder, President and COO of MicroTransponder
Jordan Curnes is a Chicago based entrepreneur and active angel investor. Jordan founded and currently manages three companies: MicroTransponder, an implantable medical device firm; Rent Like A Champion, an online real estate service; and Mobile Generation, an independent group of Verizon stores.
Follow Jordan Curnes:
About MicroTransponder, Rent Like a Champion: MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
John Weiland
Vice Chairman, President and Chief Operating Officer of C. R. Bard
John H. Weiland joined C. R. Bard, Inc. on March 1, 1996. His experience spans over 30 years in the healthcare industry with firms such as Dentsply International, Pharmacia and Baxter Healthcare Corporation. John was elected to the Board of Directors in April 2005 and assumed the title of Vice Chairman in August 2016.
Follow John Weiland:
About C. R. Bard: C. R. Bard is a developer, manufacturer, and marketer of medical technologies.
Brian R. Wamhoff
Co-Founder & COO of HemoShear Therapeutics
Wamhoff is co-founder of HemoShear and co-inventor of its technology. Wamhoff is an associate professor at the University of Virginia (UVa) and leads an NIH-funded laboratory that studies vascular disease at the Cardiovascular Division of UVa’s Department of Medicine. Wamhoff began his fellowship at UVa developing rodent models to investigate the molecular mechanisms of genes underlying vascular disease. Wamhoff was also employed by Setagon, Inc. as lead scientist to develop a novel drug-eluting stent for the treatment of blood vessel stenosis in humans. During his UVa tenure Wamhoff has obtained several million dollars in funding from Pfizer, the American Heart Association, NIH, and other organizations to study the fundamental mechanisms that regulate smooth muscle cell phenotypic switching in vascular disease, these efforts resulted in over fifteen patent filings. Wamhoff has authored or co-authored 42 articles, three book chapters, and four commentaries. Wamhoff serves as peer reviewer for more than fifteen major scientific journals and is a grant reviewer for the American Heart Association. Wamhoff has also received multiple awards, including the Robert M. Berne Trainee Achievement Award, the American Physiological Society Young Cardiovascular Investigator Award, the 2008 Atherosclerosis, Thrombosis, and Vascular Biology (ATVB) Irvine Paige Award, and the 2010 American Physiological Society New Investigator Award for Cardiovascular Research. Wamhoff obtained a B.S. in Biology with a minor in Business Administration from Rhodes College and obtained his PhD from the University of Missouri, where he developed swine models of diabetes and atherosclerosis. Wamhoff devotes philanthropic time to the community by promoting health awareness for the American Heart Association.
Follow Brian R. Wamhoff:
About HemoShear Therapeutics, University of Virginia: HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.
Justin Trout
Co-Founder & COO of Health-Ade
Follow Justin Trout:
About Health-Ade: Health-Ade kombucha offers a bubbly and delicious probiotic tea
Jerry Kuang
COO of HistoWiz
Follow Jerry Kuang:
About HistoWiz: HistoWiz provides automated histopathology for biomedical researchers.
ANDREAS MORR
COO Chief Operating Officer of HZO
Andreas Morr joined HZO in 2013 as Vice President of Engineering & Manufacturing, and now serves as the company’s Chief Operating Officer.Mr. Morr is an analytical thought leader in global operational management and technology process development with proven aptitude in establishing supply chain efficiency and high production automation solutions in hyper growth organizations and Fortune 500 companies. He has extensive experience in consumer and industrial applications, and a background in executive leadership, managing global operations, engineering and electronics manufacturing services. Andreas is also skilled in lean manufacturing, six sigma, product lifecycle management and new product introductions. He has a Bachelors in Mechanical Engineering from the Chamber of Industry & Trade in Essen, Germany.
Follow ANDREAS MORR:
About HZO: HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments.
Dawn Willoughby
Executive Vice President & Chief Operating Officer of The Clorox Company
Dawn Willoughby was named executive vice president and chief operating officer – Cleaning and International, effective September 2014. In November 2014, Willoughby also assumed responsibility for the company’s Professional Products Division. Before assuming her current position, Willoughby held numerous senior management roles with the company. She was senior vice president – general manager, Cleaning Division, with responsibility for the Laundry and Home Care business operating units; vice president – general manager, Home Care, with responsibility for eight core brands, including Clorox® disinfecting wipes, Pine-Sol® cleaners, Formula 409® and Tilex® cleaners and other home care products; and vice president – general manager, Glad Products. In that role, she helped lead the business unit’s focus on sustainable waste management, including breakthrough innovation around stronger trash bags that use significantly less plastic. She also served as vice president – Sales Planning with responsibility for the company’s Litter, Food, Charcoal, Auto and Brita® businesses. She joined Clorox in 2001 as a planning manager on a cross-functional team that drove process improvement across the company. Prior to joining Clorox, Willoughby spent nine years with Procter & Gamble, where she held several positions in sales management in the Minneapolis, Denver and Los Angeles markets. In her last assignment with P&G, she worked on the Global Business Unit for the Food & Beverage business. In May 2013, Willoughby was named one of the most influential women in the Bay Area by the San Francisco Business Times. Willoughby is on the board of directors of the American Cleaning Institute and the Alameda County Community Food Bank. She served on the board of directors for the East Bay SPCA for six years, with two years as the chair of the board. A native of Michigan, Willoughby holds a bachelor’s degree in sports management from University of Minnesota and a master’s degree in business administration from University of California – Los Angeles Anderson School of Management.
Follow Dawn Willoughby:
About The Clorox Company: The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products.
Andrew Bartynski
Co-Founder and COO of ANA Therapeutics
Andrew Bartynski is the Co-Founder and COO of ANA Therapeutics.
Follow Andrew Bartynski:
About AesculaTech, ANA Therapeutics: ANA Therapeutics is a biotech company that is developing a novel coronavirus vaccine intended to save human lives.
David Bassa
Chief Operating Officer of Claritas Pharmaceuticals
Mr. Bassa is a leading Israeli entrepreneur operating in the biotech and high-tech industries. In 2000, Mr. Bassa founded Bio-Gal, a biopharmaceutical company that subsequently merged into XTL Biopharma (NASDAQ: XTLB) for the purpose of developing Erythropoietin (“EPO”) for the treatment of multiple myeloma. Mr. Bassa was the co-founder of Sela Software Systems Ltd., a leading knowledge center and software house for the high-tech and IT industry. Mr. Bassa graduated from Bar-Ilan University with a B.A. in Economics and an M.Sc. in Computer Science. Mr. Bassa was twice awarded the President Excellency Award (1981, 2002) and managed the Israeli branch of the international AIESEC organization, of which he is a Hall of Fame member.
Follow David Bassa:
About CannaLean, Claritas Pharmaceuticals: Claritas Pharmaceuticals is pioneering the development of a next generation of cannabinoid therapeutics.
Yarone Goren
Co-Founder & COO of SteadyMD
Yarone Goren is Co-Founder and COO at SteadyMD.
Follow Yarone Goren:
About Iteration Group, SteadyMD: SteadyMD is a healthcare technology company that provides telehealth services.
Daniel Kivatinos
Co-Founder & COO of DrChrono
Daniel Kivatinos is a designer, software engineer, and entrepreneur living in Silicon Valley California. He is co-founder of DrChrono. DrChrono is a health platform for physicians, providers and patients. After completing a Master’s Degree in Computer Science, he moved into the startup scene in 2004. In 2008 Daniel started working on a concept health platform with Michael Nusimow. This concept became DrChrono. DrChrono is a culmination of people passionate in crafting only the best mobile healthcare experience. Since the inception of DrChrono, Daniel and the team have attracted thousands of physicians, millions patients, millions of appointments booked and billion dollars in medical billing processed per year through the platform. The platform has a medical API where developers can build apps on top of DrChrono. Voted as highly influential healthcare entrepreneurs by Health Science Degree and winning the 40 under 40 award.
Follow Daniel Kivatinos:
About DrChrono, onpatient: The essential platform for modern medical practices to make care more informed, more interactive, and more personalized.
Wenkang Qi
Chief Operating Officer of VitalConnect
Wenkang Qi is the Chief Operating Officer at VitalConnect.
Follow Wenkang Qi:
About VitalConnect: VitalConnect is a wearable biosensor technology for wireless hospital and remote patient monitoring.
Gajus Worthington
Healthcare Executive, COO of Chan Zuckerberg Biohub
Gajus V. Worthington is a Co-Founder of Fluidigm Corporation and has served as our President and Chief Executive Officer and a Director since our inception in June 1999. From May 1994 to April 1999, Mr. Worthington held various staff and management positions at Actel Corporation, a public semiconductor corporation. Mr. Worthington received a B.S. in Physics and an M.S. in Electrical Engineering from Stanford University.
Follow Gajus Worthington:
About Chan Zuckerberg Biohub: Chan Zuckerberg Biohub is a non-profit medical research organization started by Priscilla Chan and Mark Zuckerberg.
Curtis Spencer
Chief Operating Officer of DME Express
Curtis Spencer is one of the founders of DME Express and has served as Chief Operating Officer since the company’s inception. Curtis Spencer has over 20 years of healthcare sales & marketing, development and operating experience. Prior to developing one of the nation’s largest DME companies, Curtis Spencer held a senior management role with a $200 million, 20+ facility nursing home chain. Curtis Spencer began his healthcare career with a Beverly Enterprises as an Area Director of Sales and Marketing with responsibility for increasing the occupancy of a dozen long-term care facilities.
Follow Curtis Spencer:
About DME Express: DME Express, a provider of durable medical equipment services for the hospice industry.
Khushboo Jain
Founder & COO of Impact Guru
Follow Khushboo Jain:
About Impact Guru: We’re a Harvard incubated crowdfunding platform for nonprofits, social enterprises, startups and individuals.
Lutao Ning
COO and CEO of Koning
Lutao is the Chief Operating Officer of Koning Corporation. Koning is a medical device company seeking to revolutionize breast cancer detection through the use of cone-beam CT imaging technology. Koning’s core product, the KBCT 1000, produces a true 3D image of the breast; allowing clinicians to diagnose breast cancers far smaller and more accurately than existing technologies such as mammography and DBT. The device has regulatory approval by the US FDA, CE-Mark in Europe, China FDA, Health Canada and Australia TPG and is protected globally by over 80 patents. Koning has successfully raised over $18 M in 2 rounds of venture funding and supported by over $20 M of government grants.
Follow Lutao Ning:
About Koning: 3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
Nathan Dowden
Chief Operating Officer of Entrada Therapeutics
Nathan Dowden is the Chief Operating Officer at Entrada Therapeutics.
Follow Nathan Dowden:
About Entrada Therapeutics: Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Shaokang Wang
Co-founder and COO, Data Modeler of Infervision
Shaokang Wang is the co-founder,COO, and data modeler. Before starting Tuixiang, he worked as a data scientist in the Anthem Marketing Solutions, responsible for business and market analysis. He got his master degree of statistics at the University of Chicago.
Follow Shaokang Wang:
About Infervision: Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Jonathan Compas
Chief Operating Officer of Helinet Aviation Services
Jonathan is the Chief Operating Officer of Helinet. Jon joined Helinet in 2015 as the General Manager overseeing responsibilities for the day-to-day operations of its Van Nuys Headquarters. Prior to joining Helinet, Jonathan led sales at Apex Fuels. With revenues exceeding $135 million, Apex Fuels became the 109th fastest growing private company in the U.S. on the Inc. 500. After graduating from UC Davis, Jonathan entered the National Football League, spending time as an offensive lineman for the Raiders, Buccaneers, Patriots, and Redskins. Following the NFL, he returned to graduate school at the University of San Diego, where he completed his Master’s at the School of Business Administration.
Follow Jonathan Compas:
About Helinet Aviation Services: Helinet Aviation Services is a diversified helicopter transportation provider located in Van Nuys, California.
Mary Ray
Co-Founder & COO of MyHealthTeams
Mary Ray is the COO, co-founder and visionary behind the MyHealthTeams’ platform. Her deep understanding of consumers has contributed to her success in growing innovative companies from incubated new ventures at public companies to ‘traditional’ start-ups. She personally lost a family member to a three-decade battle with multiple sclerosis, has had friends who’ve battled cancer, who won, and lost. She’s seen her colleagues juggle work schedules to be caregivers to spouses, parents or their children facing a chronic condition. Through the experiences of her friends and family, she’s come to empathize with the loneliness they have experienced, while managing life with a chronic illness. This is what drove her and Eric Peacock to co-found MyHealthTeams. Together they are causing a tectonic shift in healthcare from a physician- and pharmaceutical-driven industry, to a consumer-driven one. Mary is a graduate of the College of William & Mary School of Business and George Mason University. She lives in San Francisco, CA with her husband and son, and is a proud fan of the three-time World Series Champions, the San Francisco Giants.
Follow Mary Ray:
About MyHealthTeams: MyHealthTeams creates social networks for chronic condition communities.
Thomas Kramer
Chief Operating Officer, Co-Founder of Cruzar Medsystems
Thomas Kramer has over 25 years of experience in medical device development. He owns and operates a medical device manufacturing center that specializes in new design and development. He has over 20 issued patents in medical devices encompassing multiple disease states. As Founder of Sirius Engineering LLC, Tom has lead multiple teams from concept to commercialization. Some of these successes include: Cruzar’s Houdini Catheter System, Vortex Medical’s AngioVac (acquired by Angio Dynamics), and Kaleidoscope Medical’s IVC filter/delivery system. Tom is a Co-founder of Cruzar MedSystems and InnoVein, Inc. serving as its Chief Operations Officer. Prior to his dedicated role in building medical device companies, Tom served as the VP of Clinical Affairs for Hansen Medical, Director of R&D and Clinical for Broncus Technologies, and Director of R&D and QA for Guidant Corporation. He holds a BSME from Cal Poly San Luis Obispo and a MSME from San Diego State University.
Follow Thomas Kramer:
About Cruzar Medsystems, Sirius Engineering, TAS Medical: Cruzar Medsystems operates in the healthcare industry manufacturing medical device designed to access peripheral vasculature.
Brandon Atkinson
Chief Operating Officer of Cleerly
Follow Brandon Atkinson:
About Cleerly: Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks.
Jason McKibbin
COO & Owner of Greenlight Guru
COO & Owner Greenlight Guru.
Follow Jason McKibbin:
About Greenlight Guru: Greenlight Guru is the only quality management software platform designed specifically for medical device companies.
Robb Hesley
COO & Senior Vice President of Product Development, Manufacturing, Quality & Information Technology of Intuity Medical
Robb Hesley has over 21 years in the medical device and pharmaceutical industries. He joined Intuity Medical in 2011 as Vice President of Corporate Development and Finance and brings extensive experience in product development, commercialization and financing of medical device companies. Serving as VP of Business Development at Hologic Inc., Robb managed all aspects of the FDA approval process for a New Drug Application (NDA), resulting in the sale of the drug for $200MM. Prior to Hologic, Robb was VP of Business Development at Adeza where he was instrumental in the company’s successful IPO and ultimate acquisition by Cytyc Corporation. Robb also held roles as VP of Business Development and R&D at Metrika, Inc., and Director of Business Development at Metra Biosystems.
Follow Robb Hesley:
About Intuity Medical: Intuity Medical develops blood glucose monitoring systems for diabetes management.
Melanie Igwe
Co-Founder & Chief Operating Officer of Drugviu
Melanie Igwe is a co-founder at Ilerasoft.
Follow Melanie Igwe:
About Drugviu: Drugviu is a population health platform that is expanding the data set in health and medication outcomes for non-white populations.
Melanie Igwe
Co-Founder & Chief Operating Officer of Drugviu
Melanie Igwe is a co-founder at Ilerasoft.
Follow Melanie Igwe:
About Drugviu: Drugviu is a population health platform that is expanding the data set in health and medication outcomes for non-white populations.
Dennis V. Boyle
President & COO of MobileHelp
With more than 20 years of executive, business operations and management experience for domestic and global companies, Dennis Boyle joined MobileHelp in June 2011. Previously, Mr. Boyle served as COO for Verio, an NTT Communications Company. In this role, he developed and executed Verio’s business strategies, while leading sales, marketing, product management, development, project management, server operations and customer support. Mr. Boyle was responsible for introducing new solutions for Verio, and directing the company’s efforts in service delivery to customers and partners worldwide. Mr. Boyle assumed this role as the company honed its strategic focus to delivering solutions and service excellence to small and midmarket businesses and partners globally. Prior to his appointment at Verio, Mr. Boyle was vice president of support services for Campus Management Corporation, an enterprise software systems provider for higher education. Here he managed operations, customer support, information technology and quality assurance, resulting in improved efficiencies that allowed the business to expand while keeping operating expenses at previous levels. Mr. Boyle holds a Bachelor of Business Administration degree from Hofstra University in New York.
Follow Dennis V. Boyle:
About MobileHelp: MobileHelp™ is a Boca Raton, Florida, healthcare technology company.
Alejandro Vargas
COO of National Medtrans Network
Follow Alejandro Vargas:
About National Medtrans Network: National MedTrans is a single source Non-Emergency Medical Transportation (NEMT) benefit management company.
J. Greg Davis
COO of Innovative Cardiovascular Solutions
Greg Davis, Executive Vice President & Chief Operating Officer, at CorVista® Health in 2017 oct
Follow J. Greg Davis:
About CorVista Health, CorVista Health, Duke University – The Fuqua School of Business, Innovative Cardiovascular Solutions: ICS develops novel solutions that offer full capture and protection from embolic material released during left-sided heart procedures.
Kristen Kerns
Chief Operating Officer of ConcertoCare
Kristen Kerns is the Chief Operating Officer at Concerto Healthcare. She has held various positions at Oak Street Health and Enlivant. Kristen attained an MBA degree in health enterprise management and a BS degree in industrial and systems engineering.
Follow Kristen Kerns:
About ConcertoCare: ConcertoCare is a provider of comprehensive care for seniors and other adults.
John A. Koch
COO and Co-Founder of MediStream
COO John graduated from Georgia Tech with a B.S. in Business Management. Shortly after graduating, he began working for a small company in the healthcare technology field as an analyst. As the company grew, he progressed from analyst to manager and then to manager of all of the operational functions of the company. With 11 years of healthcare revenue cycle experience, he has focused on customer service, vendor management, implementations, product management, marketing, operations management, and technical sales. He now serves in a similar capacity for MediStreams as COO.
Follow John A. Koch:
About MediStream: MediStream is a provider of revenue cycle management solutions for the healthcare sector.
Nick Galli
Chief Operating Officer of Interline Therapeutics
Nick Galli is the Chief Operating Officer of Interline Therapeutics. Prior to that, he was the Chief Business Officer at CytomX Therapeutics.
Follow Nick Galli:
About Interline Therapeutics: Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Paul Van Veldhuisen
Chief Operating Officer of Emmes
Paul Van Veldhuisen is the COO of The Emmes Corporation.
Follow Paul Van Veldhuisen:
About Emmes: Emmes is a clinical research collaborator.
Michael Anderson
Chief Operating Officer of Doctible
Michael Anderson is the Chief Operating Officer at Doctible.
Follow Michael Anderson:
About Doctible: Doctible is a healthcare SaaS platform for engaging patients and automating back-office workflow to help practices and health systems grow.
Christopher G. Lafarge
COO of MedicaMetrix
A.B., Biology, Harvard College; MBA, Yale University; MFS, Yale University. Mr. LaFarge has been the Founder/CEO of companies in several industries including forest products, oil and gas, and healthcare. He has successfully created, developed and brought to market a number of new products. He grew his last company to a $50M pre-money valuation before selling it to a fortune 500 company. Mr. LaFarge spent 4 years at Harvard Medical School and Beth Israel Hospital doing biomedical research.
Follow Christopher G. Lafarge:
About MedicaMetrix: Advancing Prostate Disease Management
Nico Choksi
COO of Epitel
Nico is COO at Epitel. Epitel is changing the way we diagnose and manage neurological disorders in-hospital and at home, starting with seizures. Nico was previously an investor at Unilever Ventures, focusing on enterprise technology, new commerce models, and consumer brands. He managed Unilever Ventures’ investment in CreatorIQ and was involved with Zitsticka, Jellysmack, WeGift, and True Botanicals. Nico has helped set up a venture capital seed fund, invested with London-based seed fund Force Over Mass, and helped B2B and B2C start-ups raise VC funding. He was previously a healthcare consultant in DC and the Bay Area. Nico has an MBA from London Business School and is a former Fellow of the Ellen MacArthur Foundation.
Follow Nico Choksi:
About Epitel: Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.
Patrick Lopath
COO of TECLens
Mr. Lopath has over 20 years of experience in medical device and pharmaceutical product development. He has a management consulting and operational leadership background in medical device and pharmaceutical companies. Mr. Lopath is the holder of 17 US patents in medical technology. He earned his BSE (Biomedical Engineering) and MBA from Duke University and an MS (Bioengineering) from Penn State. Mr. Lopath is a TECLens cofounder.
Follow Patrick Lopath:
About TECLens: TECLens has developed a non-invasive single treatment therapy .
Kristi Knoblich
COO of Kiva Confections
Follow Kristi Knoblich:
About Kiva Confections: Kiva Confections develops innovative ways for people to consume cannabis which nurture, enhance, and improve lives.
Michael McElhaugh
Co-Founder and Chief Operating Officer of Arbutus Biopharma
Mr. Michael J. McElhaugh, also known as Mike, co-founded Arbutus Biopharma Inc. in 2012 and serves as its Chief Operating Officer. Mr. McElhaugh has over 15 years of combined scientific and business experience. Prior to co-founding OnCore Biopharma, Inc., he was most recently Director of Hepatitis C Worldwide Commercialization at Bristol Myers Squibb where he was responsible for global hepatitis C commercialization. Prior to Bristol Myers Squibb, he was Director, Business Development and Market Analytics at Pharmasset, Inc., where he was an integral contributor to corporate strategy, strategic marketing and business development efforts. He played a key role in the sale of Pharmasset to Gilead Sciences, leading all diligence efforts and commercial analyses. Prior to joining Pharmasset, he held roles of increasing responsibility in Market Research at Viropharma, Inc., and at Merck and Co, Inc. and Thomas Jefferson University as a bench scientist. He holds a B.S. in Psychology from the Saint Joseph’s University, a M.S. in Microbiology from Thomas Jefferson University and an MBA from Cornell University.
Follow Michael McElhaugh:
About Arbutus Biopharma: Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Anup Lakare
Co-Founder and COO of Radix Health
Follow Anup Lakare:
About Radix Health: Radix Health transforms patient access.
Mike Pickering
COO/EVP of Ingenious Med
Investor, Entrepreneur, Sr Executive, Software Developer
Follow Mike Pickering:
About Ingenious Med: Ingenious Med develops and delivers inpatient practice management information systems in the United States.
Gerald Crabtree
Chief Operating Officer of PharmaCyte Biotech
Gerald Crabtree is the Chief Operating Officer of PharmaCyte Biotech and a Board member. He has spent almost 50 years working in academic, biotech and pharmaceutical companies with the majority of that vast experience being in the development of drugs and treatments for cancer. He has held positions of ever-increasing importance over that time. Crabtree’s background in the biomedical sciences has been substantial, having been involved with various biopharmaceutical companies where he has alternatively supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, and research and review articles. A highlight of Dr. Crabtree’s professional career was his tenure as Director of Project Planning and Management (Oncology and Immunology) at Bristol-Myers Squibb (“BMS”) from 1990 to 1997. While at BMS, Crabtree established and directed a department that monitored and coordinated the development of all oncologic and immunologic drugs from initial discovery through regulatory approval within BMS and served as Project Manager for the development of the major anticancer agent, Taxol®, the “number one” drug under development at BMS at that time. Taxol® ultimately became a multi-billion dollar drug for BMS and is still widely used to treat a variety of cancers. From 1989 to 1990, Crabtree was Director of Pharmacology at Viratek, Inc., a subsidiary of ICN Pharmaceuticals, Inc. in Costa Mesa, California. There he worked on the development of anticancer drugs first developed at the Nucleic Acid Research Institute (NARI, a joint venture between Eastman Kodak and ICN Pharmaceuticals) and with ribavirin (Virazole®), Viratek’s landmark antiviral drug. From 1985 to 1989, Crabtree served as Head of the Department of Molecular Pharmacology at NARI where his department was tasked with elucidating the mechanisms of action of anticancer and antiviral drugs developed by NARI chemists. From 1970 to 1985, Crabtree held several faculty positions at Brown University in Providence Rhode Island as well as at the Roger Williams Cancer Center (“RWCC”) at that institution. These positions culminated in his attaining the rank of Associate Professor of Medicine. During his time at Brown and the RWCC, Crabtree studied the mechanisms of action of putative anticancer and antiparasitic drugs and participated in clinical trials of anticancer agents. After leaving BMS in 1997, Crabtree consulted with several biotech companies, all of which were developing cancer drugs or treatments. Then, from 2000 to 2003, Crabtree served as Vice President of R&D at ETEX Corporation, a “device” company, where he was tasked with developing that company’s proprietary calcium phosphate formulations as depot/delivery platforms for cancer drugs. Upon leaving ETEX, he resumed his consulting business, which soon became focused on PhytoCeutica, Inc. located in the Yale Science Park in New Haven, Connecticut, where he assisted in the preparation and review of FDA documents, clinical study protocols, investment acquisitions, and contracts and business plans. PhytoCeutica was developing a traditional Chinese medicine four-herb combination as a treatment for liver and pancreatic cancer. During his time with PhytoCeutica, Crabtree assumed ever-increasing responsibilities and from 2009 to 2010, ultimately serving as its Interim CEO. Dr. Crabtree resumed his consulting business after leaving PhytoCeutica until he joined PharmaCyte Biotech. Crabtree received his Ph.D. in Biochemistry from the University of Alberta, Edmonton, Alberta, Canada, and has published over 80 articles in peer-reviewed journals. He was a National Cancer Institute of Canada Research Fellow. Crabtree is currently a member of the American Society of Clinical Oncology and the American Association for Cancer Research. He has served on research grant review committees for the National Institutes of Health and the American Cancer Society.
Follow Gerald Crabtree:
About PharmaCyte Biotech: PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.
Tom Westling
Chairman & COO of Rotation Medical
A co-founder of Rotation Medical, Mr. Tom Westling has more than 20 years of experience in the medical device industry. Previously, Mr. Westling led the R&D team for Cameron Health, where he developed the world’s first Subcutaneous Implantable Cardioverter Defibrillator (SICD). Earlier in his career, Mr. Westling worked for Guidant Corporation in engineering and management positions within Advanced Manufacturing Engineering, Product Development, and Manufacturing as well as Vice President of Product Development for the Cardiac Rhythm Management Group. Mr. Westling earned a B.S. in Mechanical Engineering from Kettering University and a M.S. in Mechanical Engineering from the University of Michigan.
Follow Tom Westling:
About Rotation Medical: Rotation Medical develops treatments for rotator cuff disease by reversing disease progression and restoring long-term shoulder function.
Christopher White
Chief Operating Officer of HealthCare Royalty Partners
Mr. White is responsible for leading the strategic direction, business development and corporate finance activities of Janney’s Investment Banking Division within the Capital Markets Group. Prior to joining Janney in 2011, Mr. White worked at Cowen Group, Inc. where he held a number of senior management positions including Chief of Staff, Chief Financial Officer and Chief Operating Officer. Mr. White also served as a member of the Operating Committee at Cowen and was a member of the Investment and Operating Committees of Cowen Healthcare Royalty Partners. From 2003 to 2005, Mr. White served as a member of SG Capital Partners, the Merchant Banking Division of Cowen and Company. Before joining the Merchant Banking Division, Mr. White was a senior calling officer covering the Technology and Consumer sectors in the Equity Capital Markets Group of Cowen and Company, which he joined in 1999. Mr. White has also worked at Salomon Smith Barney in the Equity Capital Markets Group and has seven years experience as a practicing securities and mergers and acquisitions lawyer. Mr. White is a graduate of Amherst College and holds a J.D. from the University of Michigan Law School.
Follow Christopher White:
About HealthCare Royalty Partners: HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors.
Phillip Laby
Co-Founder and COO of Moray Medical
Phillip Laby is the Co-Founder and COO of Moray Medical.
Follow Phillip Laby:
About Moray Medical: Moray Medical develops a structural heart robotic delivery systems for edge-to-edge valve leaflet repair.
